IGM Biosciences Inc (IGMS) — Defensive Interval Ratio
IGM Biosciences Inc (IGMS) has a Defensive Interval Ratio of 4467 days as of June 2025. Defensive assets of $74.16 Million (cash $-, short-term investments $73.66 Million, receivables $500.00K) cover 4467 days of daily cash needs of $16.60K/day.
Defensive Interval Ratio
Defensive Assets
Daily Cash Need
Current Liabilities
IGM Biosciences Inc Defensive Interval Ratio (2017–2024)
This chart shows how IGM Biosciences Inc's Defensive Interval Ratio has evolved across 8 annual periods from 2017 to 2024. As of June 2025, the ratio stands at 4467 days, meaning defensive assets of $74.16 Million can fund 4467 days of operations without new revenue. For the complete balance sheet picture, see how large is IGM Biosciences Inc's balance sheet.
Annual Defensive Interval Ratio for IGM Biosciences Inc (2017–2024)
The table below presents the year-by-year Defensive Interval Ratio for IGM Biosciences Inc from 2017 to 2024, covering 8 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. See IGM Biosciences Inc (IGMS) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
| Year | DIR (days) | Defensive Assets (USD) | Daily Cash Need | Cash | ST Investments | Change (days) |
|---|---|---|---|---|---|---|
| 2024 | 1533 days | $158.09 Million | $103.12K/day | $- | $157.29 Million | ▼ -408 days |
| 2023 | 1941 days | $225.96 Million | $116.39K/day | $- | $225.16 Million | ▼ -557 days |
| 2022 | 2499 days | $305.93 Million | $122.42K/day | $- | $305.93 Million | ▲ +1235 days |
| 2021 | 1264 days | $96.21 Million | $76.11K/day | $- | $96.21 Million | ▼ -1386 days |
| 2020 | 2650 days | $125.19 Million | $47.23K/day | $- | $125.19 Million | ▼ -5113 days |
| 2019 | 7764 days | $188.78 Million | $24.32K/day | $- | $188.74 Million | ▲ +7762 days |
| 2018 | 1 days | $35.00K | $24.36K/day | $- | $0.00 | ▲ +1 days |
| 2017 | 0 days | $0.00 | $2.67K/day | $- | $0.00 | — |